Cubist Systematic Strategies, LLC Unity Biotechnology, Inc. Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.29 $18,639 - $42,937	-33,285 Reduced 74.22%	11,563 $7,000
Q1 2022 May 16, 2022	SELL	$0.72 - $1.86 $23,705 - $61,238	-32,924 Reduced 42.33%	44,848 $50,000
Q1 2021 May 17, 2021	BUY	$5.51 - $9.42 $148,086 - $253,171	26,876 Added 52.81%	77,772 $467,000
Q4 2020 Feb 16, 2021	BUY	$3.42 - $6.36 $138,858 - $258,228	40,602 Added 394.42%	50,896 $267,000
Q3 2020 Nov 16, 2020	BUY	$2.94 - $12.43 $30,264 - $127,954	10,294 New	10,294 $36,000
Q1 2020 May 15, 2020	SELL	$5.0 - $7.6 $37,465 - $56,946	-7,493 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.99 - $8.38 $44,883 - $62,791	7,493 New	7,493 $54,000
Q2 2019 Aug 14, 2019	SELL	$7.59 - $10.21 $82,237 - $110,625	-10,835 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.65 - $16.66 $82,887 - $180,511	10,835 New	10,835 $88,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $22.2M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.